The clinical physiology of calcium homeostasis, parathyroid hormone, and calcitonin. II.
D000236:Adenoma / Q000150:complications; D000469:Alkaline Phosphatase / Q000097:blood; D002116:Calcitonin / Q000008:administration & dosage / Q000502:physiology* / Q000627:therapeutic use; D002118:Calcium / Q000097:blood / Q000378:metabolism* / Q000627:therapeutic use / Q000652:urine; D004097:Dihydrotachysterol / Q000494:pharmacology / Q000502:physiology; D004232:Diuretics / Q000627:therapeutic use; D004872:Ergocalciferols / Q000494:pharmacology / Q000502:physiology; D005260:Female; D006706:Homeostasis; D006801:Humans; D006909:Hydroxyproline / Q000652:urine; D006961:Hyperparathyroidism / Q000175:diagnosis / Q000378:metabolism; D006996:Hypocalcemia / Q000188:drug therapy; D007011:Hypoparathyroidism / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010001:Osteitis Deformans / Q000188:drug therapy; D010280:Parathyroid Glands / Q000503:physiopathology; D010281:Parathyroid Hormone / Q000502:physiology*; D010282:Parathyroid Neoplasms / Q000150:complications; D010710:Phosphates / Q000378:metabolism / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D013829:Thiadiazines / Q000627:therapeutic use
D004232:Diuretics; D004872:Ergocalciferols; D010281:Parathyroid Hormone; D010710:Phosphates; D013449:Sulfonamides; D013829:Thiadiazines; D002116:Calcitonin; D000469:Alkaline Phosphatase; D004097:Dihydrotachysterol; D006909:Hydroxyproline; D002118:Calcium